JOURNAL OF CLINICAL PATHOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2017-01-02 巴巴布莱特

这个杂志收费吗？

352 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2016-12-14 ms2534931155419844

临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表）

47 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2016-08-19 ms4817431182430527

我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。

51 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2015-12-14 大胖胖胖猫

审稿速度:2.0 | 投稿命中率:50.0
经验分享：挺适合国人投的刊，每一两期有一篇中国文章。
30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。

380 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2015-08-06 iamdqs

审稿速度:2.0 | 投稿命中率:50.0
经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。
感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。

320 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2015-06-30 edison1016

投稿一篇。。速度还挺快的

334 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2014-11-30 匿名用户

投稿一篇在此一拜。

345 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2014-09-17 匿名用户

这个杂志审稿速度快吗，求经验

389 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2014-04-28 gaoff

准备继续关注一下这个杂志

391 0

[GetPortalCommentsPageByObjectIdResponse(id=531310, encodeId=6a5f53131077, content=这个杂志收费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4a51720031, createdName=巴巴布莱特, createdTime=Mon Jan 02 09:31:00 CST 2017, time=2017-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834959, encodeId=d76f834959eb, content=临床病理学协会的官方刊物，它涵盖了组织病理学、病毒学、血液病学、微生物学、细胞病理学、化学病理学、分子病理学、法医病理学、皮肤病理学、神经病理学和免疫病理学等研究领域。收稿率37%，投稿至初步决定：平均30天，接收至发表：平均16天（线上发表）平均70天（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a645414058, createdName=ms2534931155419844, createdTime=Wed Dec 14 17:19:32 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=833249, encodeId=5085833249c7, content=我修改了一次，让加了一些内容和分析。resubmit后审稿人pass的挺快了，await me decision用了一个月。看官网接收率挺高的，快40%了，感觉比较适合中国人投。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=87eb5414016, createdName=ms4817431182430527, createdTime=Fri Aug 19 16:12:11 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=517593, encodeId=526d51e593e8, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：挺适合国人投的刊，每一两期有一篇中国文章。 30天就拿到审稿意见，很细，该发现的薄弱处都发现了，主要在reasoning和数据的解释上，大修后，2周接收。半个月后online. 总起来不算难，我的文章也不算很有新意，但要求写的完整细致。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=380, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=634c1658227, createdName=大胖胖胖猫, createdTime=Mon Dec 14 16:23:00 CST 2015, time=2015-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=514275, encodeId=27a25142e592, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：今年3月底投稿一篇，一审2个月，两个审稿人总共提了八九个问题，然后这个杂志还有一个负责检查数据统计的编辑，也提了三四个问题。总共十多个问题，给了大修。花了十天左右时间认真修改，并请国外的朋友润色了语言后修回。又审了一个多月，7月底接收。该杂志称接收后10天内能收到proof，3周内能online。期待中。 感觉这个杂志对数据量要求不大，但是研究一定要有新意。我看了一下这个杂志近年来接收的文章，基本都不是那种做个免疫组化然后做一下生存分析的类型。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=320, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6af1627858, createdName=iamdqs, createdTime=Thu Aug 06 00:52:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=513123, encodeId=7d3a51312310, content=投稿一篇。。速度还挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0ef61630413, createdName=edison1016, createdTime=Tue Jun 30 21:57:00 CST 2015, time=2015-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508034, encodeId=1b0650803443, content=投稿一篇在此一拜。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=345, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Nov 30 22:21:00 CST 2014, time=2014-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506091, encodeId=a8f350609197, content=这个杂志审稿速度快吗，求经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=389, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Sep 17 16:21:00 CST 2014, time=2014-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=502620, encodeId=adf850262075, content=准备继续关注一下这个杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=391, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5c597618, createdName=gaoff, createdTime=Mon Apr 28 15:19:00 CST 2014, time=2014-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=484679, encodeId=77734846e9da, content=Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220 这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=473, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25d841823, createdName=myjnqr, createdTime=Thu Sep 29 10:24:00 CST 2011, time=2011-09-29, status=1, ipAttribution=)]

2011-09-29 myjnqr

Authors are able to make their articles freely available online, immediately on publication, for a fee, using the Unlocked service. This service is available to any author publishing original research in a BMJ Journal for a fee of £1,200(+VAT)/€1,775(+VAT)/$2,220
这是什么意思？如果不立即发表就不收费吗？还是都需要收费呀？

473 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务